Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk

[1]  M. Saadat,et al.  Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures , 2009, Breast Cancer Research and Treatment.

[2]  R. Freimanis,et al.  Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. , 2008, Carcinogenesis.

[3]  R. Kittles,et al.  Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans , 2008, International journal of cancer.

[4]  S. Juo,et al.  Association between Polymorphisms in DNA Base Excision Repair Genes XRCC1, APE1, and ADPRT and Differentiated Thyroid Carcinoma , 2008, Clinical Cancer Research.

[5]  Chen-Yang Shen,et al.  Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan , 2008, Breast Cancer Research and Treatment.

[6]  P. Brennan,et al.  Polymorphisms in three base excision repair genes and breast cancer risk in Thai women , 2008, Breast Cancer Research and Treatment.

[7]  J. Meza,et al.  Prevalence of BER gene polymorphisms in sporadic breast cancer. , 2008, Oncology reports.

[8]  R. Duggirala,et al.  Genetic polymorphisms in OGG1 and their association with angiomyolipoma, a benign kidney tumor in patients with tuberous sclerosis , 2008, Cancer biology & therapy.

[9]  C. Ulrich,et al.  Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer (Cancer Epidemiology Biomarkers and Prevention (2005) 14, (2524-2530)) , 2008, Cancer Epidemiology Biomarkers & Prevention.

[10]  A. Neugut,et al.  Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[11]  F. Schmitt,et al.  DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population , 2007, Breast Cancer Research and Treatment.

[12]  Giu-Cheng Hsu,et al.  Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility. , 2006, Carcinogenesis.

[13]  R. Hoover,et al.  Serum concentrations of estrogens, sex hormone‐binding globulin, and androgens and risk of breast cancer in postmenopausal women , 2006, International journal of cancer.

[14]  C. Fann,et al.  A Comparison of Individual Genotyping and Pooled DNA Analysis for Polymorphism Validation Prior to Large‐Scale Genetic Studies , 2006, Annals of human genetics.

[15]  A. Neugut,et al.  OGG1 Polymorphisms and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[16]  R. Millikan,et al.  XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. , 2006, Cancer research.

[17]  X. Shu,et al.  Functional Ser326Cys Polymorphism in the hOGG1 Gene Is Not Associated with Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  S. Chanock,et al.  Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  J. Heesterbeek,et al.  The Effect of DNA Repair Defects on Reproductive Performance in Nucleotide Excision Repair (NER) Mouse Models: An Epidemiological Approach , 2005, Transgenic Research.

[20]  C. Ulrich,et al.  Interindividual Variation in Nucleotide Excision Repair Genes and Risk of Endometrial Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  N. Rothman,et al.  Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China , 2005, International journal of cancer.

[22]  Hongbing Shen,et al.  XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  M. Ishizuka,et al.  Nitric oxide enhances catechol estrogen-induced oxidative stress in LNCaP cells , 2005, Free radical research.

[24]  Magnar Bjørås,et al.  Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harbouring the hOGG1-Cys326 polymorphic variant , 2005, Nucleic acids research.

[25]  A. Neugut,et al.  Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[26]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility , 2005, International journal of cancer.

[27]  N. Dalay,et al.  Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients , 2004, Experimental & Molecular Medicine.

[28]  Seung-Yong Jeong,et al.  Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients , 2004, Human Genetics.

[29]  Chen-Yang Shen,et al.  Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1 , 2004, Cancer Research.

[30]  B. Bapat,et al.  Genomic instability and cancer. , 2003, Current molecular medicine.

[31]  J. Park,et al.  Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. , 2003, Carcinogenesis.

[32]  X. Shu,et al.  Plasma sex steroid hormones and breast cancer risk in Chinese women , 2003, International journal of cancer.

[33]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.

[34]  W. Han,et al.  hOGG1 Ser326Cys Polymorphism and Breast Cancer Risk among Asian Women , 2003, Breast Cancer Research and Treatment.

[35]  Hung-Ming Wang,et al.  The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  K. Hemminki,et al.  Single nucleotide polymorphisms in the XPG gene: Determination of role in DNA repair and breast cancer risk , 2003, International journal of cancer.

[37]  J. Bolton,et al.  Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. , 2001, Chemical research in toxicology.

[38]  J. Liehr,et al.  Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development , 2001 .

[39]  M J Khoury,et al.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.

[40]  J. Liehr,et al.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations. , 2000, Journal of the National Cancer Institute. Monographs.

[41]  M. Kitajima,et al.  Increased formation of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. , 2000, Cancer letters.

[42]  R. Parshad,et al.  XPD polymorphisms: effects on DNA repair proficiency. , 2000, Carcinogenesis.

[43]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.

[44]  D. Kleinbaum,et al.  Regression models for ordinal responses: a review of methods and applications. , 1997, International journal of epidemiology.

[45]  C. Yue,et al.  Novel patterns of p53 abnormality in breast cancer from Taiwan: experience from a low-incidence area. , 1997, British Journal of Cancer.

[46]  D. Kleinbaum,et al.  Interpreting the literature in obstetrics and gynecology: II. Logistic regression and related issues. , 1991, Obstetrics and gynecology.

[47]  J. Bolton,et al.  Potential mechanisms of estrogen quinone carcinogenesis. , 2008, Chemical research in toxicology.

[48]  I. Ruczinski,et al.  Breast Cancer Risk is not Associated with Polymorphic Forms of Xeroderma Pigmentosum Genes in a Cohort of Women from Washington County, Maryland , 2006, Breast Cancer Research and Treatment.

[49]  M. Butterworth,et al.  Detection of DNA strand breaks and oxidized DNA bases at the single‐cell level resulting from exposure to estradiol and hydroxylated metabolites , 2005, Environmental and molecular mutagenesis.

[50]  J. Russo,et al.  Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.

[51]  P. Walsh.  Associations between hOGG1 sequence variants and prostate cancer susceptibility. , 2002, The Journal of urology.

[52]  L. Marchand,et al.  Association of the hOGG 1 Ser 326 Cys Polymorphism with Lung Cancer Risk 1 , 2002 .

[53]  J. Bolton,et al.  Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. , 2001, Chemical research in toxicology.

[54]  C. W. Wu,et al.  A case-control study of breast cancer in Taiwan--a low-incidence area. , 1997, British Journal of Cancer.

[55]  J. Yager,et al.  Molecular mechanisms of estrogen carcinogenesis. , 1996, Annual review of pharmacology and toxicology.

[56]  Yager Jd,et al.  Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .